Rezo Therapeutics is based in San Francisco, California. It has raised $78M in total funding. Latest round: Series A.
Rezo Therapeutics is based in San Francisco, California. Rezo Therapeutics has raised $78M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in November 2022. The round record for Rezo Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include SR One, a16z Bio + Health, Norwest Venture Partners, SV Angel, Liquid 2 Ventures, Hawktail. 6 distinct backers are named across the disclosed rounds.
Every Rezo Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in San Francisco at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026